Duke and the Harvard-MIT Center for Regulatory Science
Anticancer Drug Development Workshop

For Early-Career Drug Development Investigators and Fellows


Duke and the Harvard-MIT Center for Regulatory Science Anticancer Drug Development Workshop is an advanced clinical development workshop discussing the specific strategies leading to successful development pathways for new anticancer agents. The program features faculty speakers from the U.S. Food and Drug Administration (FDA), Duke University and the Harvard-MIT Center for Regulatory Science representing the full spectrum of anticancer drug development processes as well as regulatory science activities, and will include interactive, moderated discussions. The workshop is targeted towards early-career drug development investigators and fellows, but anyone with limited knowledge of regulatory science will benefit.

The FDA defines regulatory science as the science of developing new tools, standards and approaches to assess the safety, efficacy, quality and performance of all FDA-regulated products. Within this guidance, regulatory science will require many elements of translational medicine including innovation in measurement, trials focused on evidence generation, and analysis of policies and their impact.


Scholarships covering one night’s accommodation at the Le Méridien Cambridge-MIT Hotel for academic investigators traveling from outside the Boston area are no longer available.


Industry Fee: $1200

No charge to attend for academic participants

 

 

 

Sponsors

genentech

DEAN’S CIRCLE

DEAN’S CIRCLE